Search results
Results from the WOW.Com Content Network
The term variant of concern (VOC) for SARS-CoV-2, which causes COVID-19, is a category used for variants of the virus where mutations in their spike protein receptor binding domain (RBD) substantially increase binding affinity (e.g., N501Y) in RBD-hACE2 complex (genetic data), while also being linked to rapid spread in human populations ...
On 26 November at an emergency meeting in Geneva, Switzerland WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution designated PANGO lineage B.1.1.529 a variant of concern (VOC) and gave it the designation Omicron (skipping Nu and Xi, the next letters in the Greek alphabet in keeping with its nomenclature protocol introduced for the Delta variant).
The timeline of the COVID-19 pandemic lists the articles containing the chronology and epidemiology of SARS-CoV-2, [1] the virus that causes the coronavirus disease 2019 and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 occurred in Wuhan, People's Republic of China, on or about 17 November 2019. [2]
The JN.1 variant may be "intensifying the spread of COVID-19 this winter," the CDC said in an update on Jan. 5. Waning immunity, low COVID-19 vaccine uptake, and holiday gatherings likely also ...
JN.1 is a COVID-19 variant that descended from BA.2.86, explains infectious disease expert Amesh Adalja, M.D., a senior scholar at the Johns Hopkins Center for Health Security. JN.1 is “another ...
The variant's parent lineage, BA.2.86, has a large number of mutations compared to the original version of omicron — and those changes have enabled the virus to sidestep existing immunity ...
On July 27, based on updated information for fully vaccinated people that new evidence on the Delta variant had provided, CDC added a recommendation for those people to wear a mask in public indoor settings in areas of substantial or high transmission. CDC also made other recommendations based on this information. [52]
In December, studies, some of which using large nationwide datasets from either Israel and Denmark, found that vaccine effectiveness of multiple common two-dosed COVID-19 vaccines is substantially lower against the Omicron variant than for other common variants including the Delta variant, and that a new (often a third) dose – a booster dose ...